Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting, taking place April 11–15, 2026, in Toronto, Canada. At the event, Delcath's Hepatic Delivery System for use in percutaneous hepatic perfusion will be featured in three presentations. On April 13, 2026, at 2:40 PM ET, Dr. Eric We.